CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 39 enrolled
Drug / intervention
CGMdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06141941
NCT06141941N/ACompleted
CompareCT.gov

Does the Use of Continuous Glucose Monitoring (CGM) in the Immediate Postpartum Period in Women With Pregestational Diabetes Admitted to the Hospital Decrease Hypoglycemic Episodes

University of Iowa·interventional·Posted Nov 21, 2023·Updated Apr 9, 2026

In Brief

A clinical study evaluating CGM for Pregestational Diabetes. Completed, enrolled 39 participants across 1 site.

Detailed Summary

This study will examine whether continuous glucose monitoring in patients hospitalized in the immediate postpartum period is more effective than traditional point of care glucose testing in identifying patients with hypoglycemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPregestational Diabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedNov 21, 2023
Enrollment StartJun 1, 2021
Primary CompletionApr 30, 2024
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 2.6 years ago

Interventions

CGMdevice

Continuous glucose monitoring